Your browser doesn't support javascript.
loading
Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease.
Otten, Antonius T; van der Meulen, Hedwig H; Steenhuis, Maurice; Loeff, Floris C; Touw, Daan J; Kosterink, Jos G W; Frijlink, Henderik W; Rispens, Theo; Dijkstra, Gerard; Visschedijk, Marijn C; Bourgonje, Arno R.
Afiliação
  • Otten AT; Department of Gastroenterology and Hepatology, University Medical Centre Groningen, Groningen, the Netherlands.
  • van der Meulen HH; Department of Gastroenterology and Hepatology, University Medical Centre Groningen, Groningen, the Netherlands.
  • Steenhuis M; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, the Netherlands.
  • Loeff FC; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, the Netherlands.
  • Touw DJ; Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
  • Kosterink JGW; Department of PharmacoTherapy, Epidemiology and Economy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
  • Frijlink HW; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
  • Rispens T; Department of Immunopathology, Sanquin Research, Amsterdam, the Netherlands.
  • Dijkstra G; Department of Gastroenterology and Hepatology, University Medical Centre Groningen, Groningen, the Netherlands.
  • Visschedijk MC; Department of Gastroenterology and Hepatology, University Medical Centre Groningen, Groningen, the Netherlands.
  • Bourgonje AR; Department of Gastroenterology and Hepatology, University Medical Centre Groningen, Groningen, the Netherlands.
Inflamm Bowel Dis ; 30(3): 325-335, 2024 Mar 01.
Article em En | MEDLINE | ID: mdl-37265165
BACKGROUND: Therapeutic drug monitoring provides important guidance for treatment of patients with inflammatory bowel disease (IBD) and could help to early identify treatment failure. This study aimed to validate a finger prick-based capillary blood sampling technique to measure biological trough levels and C-reactive protein (CRP) and evaluate patient performance and -support. METHODS: In this prospective cohort study, patients with IBD receiving infliximab (IFX) or vedolizumab (VEDO) therapy performed finger prick-based capillary blood sampling at home. Additionally, blood was collected through routinely performed in-hospital venepuncture prior to biological infusion. IFX, VEDO, and CRP concentrations were measured by enzyme-linked immunosorbent assay. The concordance between methods was statistically evaluated and a survey was conducted to assess practicality and patient support. RESULTS: In total, 81 patients (46 IFX, 35 VEDO) were enrolled. Mean differences between both methods were 0.42 (95% confidence interval, -1.74 to 2.58) µg/mL for IFX and 0.72 (95% confidence interval, -5.50 to 6.94) µg/mL for VEDO. Passing-Bablok regressions demonstrated no evidence for systematic or proportional biases. Venous and capillary IFX (ρ = 0.96, P < .001) and VEDO (ρ = 0.97, P < .001) levels strongly correlated and showed high intermethod agreement (Cohen's kappa: IFX = 0.82; VEDO = 0.94). Similarly, venous and capillary CRP levels were strongly correlated (ρ = 0.99, P < .001). Most patients (>95%) were able to successfully perform the self-sampling at home without prior instructions. CONCLUSIONS: This study clinically validated a finger prick-based capillary blood self-sampling technique allowing concomitant home monitoring of biological levels and CRP for patients with IBD, who reported substantial support, tolerability, and practicality.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Doenças Inflamatórias Intestinais / Anticorpos Monoclonais Humanizados Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Doenças Inflamatórias Intestinais / Anticorpos Monoclonais Humanizados Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article